Viking Therapeutics (VKTX) Earnings
|
Expand Research on VKTX
| Next EPS Date | 7/24/24 *Est. | EPS Growth Rate | -4.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +1.6% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +6.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4/24/24 | Q124 | -$0.26 | -$0.28 | +$0.02 | N/A | N/A | N/A |  | | Details | |
| 2/7/24 | Q423 | -$0.25 | -$0.26 | +$0.01 | N/A | N/A | N/A | | | Details | |
| 10/25/23 | Q323 | -$0.23 | -$0.22 | -$0.01 | N/A | N/A | N/A | | | Details | |
| 7/26/23 | Q223 | -$0.19 | -$0.19 | $0.00 | N/A | N/A | N/A | | | Details | |
| 4/26/23 | Q123 | -$0.25 | -$0.24 | -$0.01 | N/A | N/A | N/A | | | Details | |
| 2/8/23 | Q422 | -$0.26 | -$0.23 | -$0.03 | N/A | N/A | N/A | | | Details | |
| 3/21/23 | Q422 | N/A | -$0.23 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 10/26/22 | Q322 | -$0.17 | -$0.23 | +$0.06 | N/A | N/A | N/A | | | Details |
